Emerging Markets Earnings: Eli Lilly Finds Room To Grow In Asia, Brazil
This article was originally published in PharmAsia News
Executive Summary
Eli Lilly finds a bright spot in emerging markets for the third quarter with insulin a prime driver of growth.